[October 18, 2017] |
|
Cholera Global Clinical Trials Review, H1, 2017 - Research and Markets
The "Cholera
Global Clinical Trials Review, H1, 2017" clinical trials has
been added to Research and Markets' offering.
The clinical trial report, Cholera Global Clinical Trials Review, H1,
2017" provides an overview of Cholera clinical trials scenario. This
report provides top line data relating to the clinical trials on
Cholera. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report
offers coverage of disease clinical trials by region, country (G7 & E7),
phase, trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials).
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe. Clinical
trials database undergoes periodic update by dynamic process. The report
enhances the decision making capabilities and helps to create an
effective counter strategies to gain competitive advantage.
Scope of the Report:
-
The report provides a snapshot of the global cinical trials landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to Buy:
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by providing
a comparative scenario of completed and uncompleted (terminated,
suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Companies Mentioned
-
International Centre for Diarrhoeal Disease Research Bangladesh
-
Sanofi
-
PaxVax Inc
-
Eubiologics Co Ltd
-
QPS Holdings LLC
-
NIZO food research BV
-
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd
-
Jean Brown Research
-
FrieslandCampina Innovation International
-
Avail Clinical Research LLC
For more information about this clinical trials report visit https://www.researchandmarkets.com/research/m2mztj/cholera_global
View source version on businesswire.com: http://www.businesswire.com/news/home/20171018005707/en/
[ Back To TMCnet.com's Homepage ]
|